Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Genus plc
  6. News
  7. Summary
    GNS   GB0002074580


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Genus : UK firm Genus sees challenges as it restocks China pig farms

02/25/2021 | 06:25am EDT
FILE PHOTO: Pigs are seen at a farm in Neihuang county

BEIJING (Reuters) - British livestock genetics firm Genus sees potential short-term challenges in its drive to help restock China's massive pig farming industry which has faced a surge in disease outbreaks over the winter, the chief executive said on Thursday.

The supplier to a third of China's top 50 producers with breeding pigs has seen strong growth and gained Chinese market share during a rapid restocking of the world's largest hog herd that was devastated by African swine fever in 2018 and 2019.

Genus' shares slid 6% on Thursday, their biggest percentage fall since May 2020, after the company also forecast lower growth and increased currency headwinds in the second half.

Chief Executive Stephen Wilson said Chinese pig farms had seen "a lot of disease" over the winter, making it harder to keep the firm's pigs healthy, particularly during transport when there is a major risk of virus transmission.

"It's going to make the next few months potentially have some challenges," he told Reuters, adding customers could review restocking plans as a result of the disease outbreaks although Genus had not seen any "major changes" yet.

"The demand side continues to be very healthy," he said.

China's restocking effort helped Genus lift first half revenues by 6% to 285.7 million pounds ($404.6 million), while profit after tax for the period to the end of December was up 26% at 30.3 million pounds.

China's hog futures have rallied more than 10% since launching in January over reports of disease outbreaks. Some analysts estimate about 20% of sows in northern China have been affected.

Genus was considering dedicating a fleet of trucks for transporting its pigs to reduce risk of disease transmission and was looking at developing its own diagnostics to detect infection accurately without producing false positives, Wilson said.

But he said the outbreaks would keep pig prices in China high in the medium term and sustain strong demand for genetics.

"There's still a lot of expansion and a lot of empty farms and still a lot of slaughter pigs that are being rebred as sows which have much lower productivity," said Wilson.

($1 = 0.7061 pounds)

(Reporting by Dominique Patton; Editing by Edmund Blair)

ę Reuters 2021
All news about GENUS PLC
09/24WALL STREET STOCK EXCHANGE : The day after tomorrow
09/24ANALYST RECOMMENDATIONS : Boohoo, Coca-Cola, Monster Beverage, Molson Coors, Philip Morris..
09/15GENUS : Liberum Lifts Genus' PT, Reiterates Buy Rating
09/09GENUS : Peel Hunt Downgrades Genus To Hold From Buy, Keeps PT
09/09FTSE Down, Hochschild Shares Expected to Rise as Investors Digest Rare Earths Project
09/09FTSE 100 Retreats Again as Travel, Retail Stocks Fall
09/09FTSE 100 records worst session in 3 weeks on stronger pound
09/09GENUS : FY21 Profit Rises on Back of Porcine Genetics Revenue Growth
09/09GENUS : Earnings Flash (GNS.L) GENUS Reports FY21 EPS GBX72.60
09/09GENUS PLC : Reports Preliminary Results for the Year Ended 30 June 2021
More news
Analyst Recommendations on GENUS PLC
More recommendations
Sales 2021 569 M 779 M 779 M
Net income 2021 51,1 M 69,9 M 69,9 M
Net Debt 2021 82,1 M 112 M 112 M
P/E ratio 2021 70,6x
Yield 2021 0,56%
Capitalization 3 605 M 4 942 M 4 939 M
EV / Sales 2021 6,48x
EV / Sales 2022 6,16x
Nbr of Employees 3 100
Free-Float 99,4%
Duration : Period :
Genus plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENUS PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 5 550,00 GBX
Average target price 5 499,43 GBX
Spread / Average Target -0,91%
EPS Revisions
Managers and Directors
Stephen Wilson Chief Executive Officer & Executive Director
Alison Henriksen Chief Financial Officer & Director
Iain G. T. Ferguson Non-Executive Chairman
Elena Rice Chief Scientific Officer
Bill Christianson Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
GENUS PLC32.86%4 950
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
CELLTRION, INC.-25.49%31 745
SEAGEN INC.-7.88%29 353